GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Arcadia Biosciences Inc (FRA:17D) » Definitions » Cyclically Adjusted PB Ratio

Arcadia Biosciences (FRA:17D) Cyclically Adjusted PB Ratio : 0.12 (As of Jun. 10, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Arcadia Biosciences Cyclically Adjusted PB Ratio?

As of today (2024-06-10), Arcadia Biosciences's current share price is €2.80. Arcadia Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €24.18. Arcadia Biosciences's Cyclically Adjusted PB Ratio for today is 0.12.

The historical rank and industry rank for Arcadia Biosciences's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:17D' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.08   Med: 0.29   Max: 1.44
Current: 0.11

During the past years, Arcadia Biosciences's highest Cyclically Adjusted PB Ratio was 1.44. The lowest was 0.08. And the median was 0.29.

FRA:17D's Cyclically Adjusted PB Ratio is ranked better than
97% of 1365 companies
in the Consumer Packaged Goods industry
Industry Median: 1.34 vs FRA:17D: 0.11

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Arcadia Biosciences's adjusted book value per share data for the three months ended in Mar. 2024 was €7.170. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €24.18 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Arcadia Biosciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Arcadia Biosciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arcadia Biosciences Cyclically Adjusted PB Ratio Chart

Arcadia Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.12

Arcadia Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.44 0.36 0.31 0.12 0.09

Competitive Comparison of Arcadia Biosciences's Cyclically Adjusted PB Ratio

For the Packaged Foods subindustry, Arcadia Biosciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arcadia Biosciences's Cyclically Adjusted PB Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Arcadia Biosciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Arcadia Biosciences's Cyclically Adjusted PB Ratio falls into.



Arcadia Biosciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Arcadia Biosciences's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2.80/24.18
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arcadia Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Arcadia Biosciences's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=7.17/131.7762*131.7762
=7.170

Current CPI (Mar. 2024) = 131.7762.

Arcadia Biosciences Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.000 100.560 0.000
201409 -1,542.951 100.428 -2,024.581
201412 -1,446.045 99.070 -1,923.437
201503 -1,785.696 99.621 -2,362.072
201506 783.811 100.684 1,025.860
201509 711.255 100.392 933.610
201512 668.604 99.792 882.894
201603 575.990 100.470 755.464
201606 501.820 101.688 650.302
201609 440.863 101.861 570.339
201612 378.421 101.863 489.550
201703 322.089 102.862 412.626
201706 246.334 103.349 314.090
201709 167.760 104.136 212.288
201712 126.823 104.011 160.678
201803 8.722 105.290 10.916
201806 58.303 106.317 72.265
201809 92.770 106.507 114.780
201812 94.362 105.998 117.310
201903 4.689 107.251 5.761
201906 46.805 108.070 57.072
201909 56.896 108.329 69.211
201912 32.084 108.420 38.996
202003 46.078 108.902 55.757
202006 42.853 108.767 51.918
202009 35.366 109.815 42.439
202012 67.773 109.897 81.266
202103 70.083 111.754 82.639
202106 62.374 114.631 71.703
202109 61.067 115.734 69.531
202112 49.616 117.630 55.583
202203 49.533 121.301 53.811
202206 45.715 125.017 48.187
202209 41.098 125.227 43.248
202212 32.228 125.222 33.915
202303 18.325 127.348 18.962
202306 14.879 128.729 15.231
202309 13.110 129.860 13.304
202312 9.161 129.419 9.328
202403 7.170 131.776 7.170

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Arcadia Biosciences  (FRA:17D) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Arcadia Biosciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Arcadia Biosciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Arcadia Biosciences (FRA:17D) Business Description

Traded in Other Exchanges
Address
5950 Sherry Lane, Suite 215, Dallas, TX, USA, 75225
Arcadia Biosciences Inc is a producer and marketer of innovative, plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements primarily in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care.

Arcadia Biosciences (FRA:17D) Headlines

No Headlines